Variations in serum sphingolipid levels associate with liver fibrosis progression and poor treatment outcome in hepatitis C virus but not hepatitis B virus infection

MLA

Christoph Sarrazin, et al. “Variations in Serum Sphingolipid Levels Associate with Liver Fibrosis Progression and Poor Treatment Outcome in Hepatitis C Virus but Not Hepatitis B Virus Infection.” Hepatology (Baltimore, Md.), vol. 61, no. 3, Sept. 2014. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....ac6561c37797c7b7c7898494190b3b30&authtype=sso&custid=ns315887.

APA

Christoph Sarrazin, Daniel Fitting, Julia Dietz, Nerea Ferreirós, Stefan Zeuzem, C. Berkowski, Stephanie Schwalm, Dimitra Bon, Josef Pfeilschifter, Eva Herrmann, & Georgios Grammatikos. (2014). Variations in serum sphingolipid levels associate with liver fibrosis progression and poor treatment outcome in hepatitis C virus but not hepatitis B virus infection. Hepatology (Baltimore, Md.), 61(3).

Chicago

Christoph Sarrazin, Daniel Fitting, Julia Dietz, Nerea Ferreirós, Stefan Zeuzem, C. Berkowski, Stephanie Schwalm, et al. 2014. “Variations in Serum Sphingolipid Levels Associate with Liver Fibrosis Progression and Poor Treatment Outcome in Hepatitis C Virus but Not Hepatitis B Virus Infection.” Hepatology (Baltimore, Md.) 61 (3). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....ac6561c37797c7b7c7898494190b3b30&authtype=sso&custid=ns315887.